Evidence map›Paper›PMID 24050701›Full record

ReviewAnnual review of pharmacology and toxicology2014

Antiparasitic chemotherapy: from genomes to mechanisms.

David Horn, Manoj T Duraisingh

Abstract readReview
In one paragraph

Review in Annual review of pharmacology and toxicology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Mutation Characteristics and Phylogenetic Analysis of FiveAnimals : an open access journal from MDPI · 2022
    Article
  6. Article
  7. Article
  8. A Review ofThe Malaysian journal of medical sciences : MJMS · 2019
    Review
  9. Article
  10. Clinical and veterinary trypanocidal benzoxaboroles target CPSF3.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  11. Review
  12. Article
  13. Review
  14. Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David HornDivision of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom; email: d.horn@dundee.ac.uk.
Manoj T Duraisingh

Funding

Functional analysis of erythrocyte determinants of malaria infectionR01AI091787 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI DURAISINGH, MANOJ T · 2011 to 2015
$2.0M
Genetic validation of essential asexual stage genes in Plasmodium falciparumR21AI088314 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI DURAISINGH, MANOJ T · 2010 to 2011
$448k
Medical Research Council MR/K000500/1NIAID NIH HHS 5R01AI091787NIAID NIH HHS 5R21AI088314NIAID NIH HHS R01 AI091787NIAID NIH HHS R21 AI088314Wellcome Trust 093010/Z/10/ZWellcome Trust 100320
6 · The paper itself

Abstract

Owing to the absence of antiparasitic vaccines and the constant threat of drug resistance, the development of novel antiparasitic chemotherapies remains of major importance for disease control. A better understanding of drug transport (uptake and efflux), drug metabolism and the identification of drug targets, and mechanisms of drug resistance would facilitate the development of more effective therapies. Here, we focus on malaria and African trypanosomiasis. We review existing drugs and drug development, emphasizing high-throughput genomic and genetic approaches, which hold great promise for elucidating antiparasitic mechanisms. We describe the approaches and technologies that have been influential for each parasite and develop new ideas for future research directions, including mode-of-action studies for drug target deconvolution.

Indexed as

Genome, ProtozoanMolecular Targeted TherapyAntiparasitic AgentsClinical Trials as TopicDrug DesignDrug ResistanceGenomicsHigh-Throughput Nucleotide SequencingHumansMalariaPhenotypeTrypanosomiasisAntiparasitic Agents

Identifiers

PMID24050701
PMCPMC4381542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.